Copyright 2017 Global Healthcare Resources. All rights reserved.


CANCER GENOMIC

PROFILING PROGRAM


  • Each cancer diagnosis is personal to the individual and their treatment plans should be equally personal.
  • Genomic profiling of an individual’s cancer is the most significant advance in personalizing cancer treatment.

WGA’s Cancer Genomic Profiling reports provide the following valuable information:

  • Details that confirm diagnosis
  • Identifies inherited family risk
  • Pharmacogenomics: Understanding of the individual’s drug response and metabolizing profile 
  • Identifies the individual’s potential for targeted therapies, immunotherapies and clinical trials

Fill out the form below to download a PDF and learn more about Cancer Genomic  Profiling Program

DOWNLOAD NOW

Access to Tomorrow’s TreatmentsNOW


CANCER GENOMIC

PROFILING PROGRAM


  • Significantly contributes to diagnosis
  • Highlights inherited family risks for follow-up
  • Access to leading tumor genomic profiling tests available at the time of your diagnosis, such as tumor DNA sequencing
  • Identifies the patient's potential for immunotherapy or clinical trial participation
  • Increasing utility to understand your response to cancer drug regimens
  • Access to leading tumor genomic profiling tests available at the time of your diagnosis
  • Lifetime participation available – Program participation may be continued on a direct bill basis upon termination of employment when covered through an employer group offering
  • Family program options available
  • WGA constantly monitors enhancement to tumor genomic testing to ensure you always have access to the most up-to-date leading and available advances


Wamberg Genomic Advisors (“WGA”) is proud to deliver genomic products to employers and their employees.


Advanced cancer genomic profiling uses techniques such as DNA sequencing to identify mutations found in a patients cancer that can add significantly to your Oncologists ability to more rapidly identify the most effective treatment options for you.


Wamberg Genomic Advisors (“WGA”) is proud to deliver genomic products to employers and their employees. 

Access to Tomorrow’s Treatments,  NOW 


  • Each cancer diagnosis is personal to the individual and their treatment plans should be equally personal.
  • Genomic profiling of an individual’s cancer is the most significant advance in personalizing cancer treatment.

WGA’s Cancer Genomic Profiling reports provide the following valuable information:

  • Details that confirm diagnosis
  • Identifies inherited family risk
  • Pharmacogenomics: Understanding of the individual’s drug response and metabolizing profile 
  • Identifies the individual’s potential for targeted therapies, immunotherapies and clinical trials
Fix the following errors:
Hide